H2020-IMI2-2020-20-02: Innovations to accelerate vaccine development vaccine development and manufacture

The overall objective is to accelerate and de-risk the development of new vaccines by incorporating scientific and technological advances from the academic and biotech sectors into industry, and to develop more predictive biological and mathematical models of vaccine performance. The topic is composed of four subtopics: - Systems-immunology platform for model development,- CHIMs,- State-of-art innovations in human in vitro mucosa models and assays,- Biomanufacturing platforms using mathematical modelling.Type of action: Research and Innovation Action.